Search PubMedSearch

PubMed · 8935907

Randomization test for coupled data.

Abstract

Coupled data arise in perceptual research when subjects are contributing two scores to the data pool. These two scores, it can be reasonably argued, cannot be assumed to be independent of one another; therefore, special treatment is needed when performing statistical inference. This paper shows how the Type I error rate of randomization-based inference is affected by coupled data. It is demonstrated through Monte Carlo simulation that a randomization test behaves much like its parametric counterpart except that, for the randomization test, a negative correlation results in an inflation in the Type I error rate. A new randomization test, the couplet-referenced randomization test, is developed and shown to work for sample sizes of 8 or more observations. An example is presented to demonstrate the computation and interpretation of the new randomization test.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B D Zumbo. 1996. Randomization test for coupled data.. https://doi.org/10.3758/bf03206822

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Assessment of blinding in pharmacotherapy and noninvasive neuromodulation randomized controlled trials for neuropathic pain in adults.

In randomized controlled trials (RCTs), study participants and research personnel are often blinded to minimize biases related to knowing treatment allocation. To determine if blinding was effective, participants may be asked which treatment they believe they received ("treatment guess"). This descriptive review characterized blinding assessment (BA) reporting in pharmacotherapy and neuromodulation neuropathic pain RCTs. Of 288 papers, 36 (12.5%) reported a BA. One paper reported the results of 2 studies, so in total 37 studies with a BA were assessed. Of these, 19 were crossover, 17 parallel, and 1 partial crossover in design. All 37 studies assessed participant blinding, and 10 also assessed investigator blinding. Approximately 27% included an "unsure" answer option for treatment guess, and 38% asked the reason for the guess. There were no clear patterns in BA reporting across time nor based on treatment type. Seventeen trials provided sufficient data to calculate Bang Blinding Index (BI) to determine blinding success. Participants remained blinded (BI = 0 &#xb1; 0.2) in 10/17 placebo and 10/17 treatment arms, 6 placebo and 5 treatment arms had a BI > 0.2 suggesting possible unblinding, whereas 1 placebo and 2 treatment arms had a BI < -0.2 suggesting misinformed guessing. Overall, we found that BAs are done in a minority of published neuropathic pain trials and with variable methodology. Given the importance of minimizing risk of bias because of treatment unblinding, future studies should consider including BAs, and further consensus building is necessary to determine if and how BAs should be conducted and interpreted in analgesic clinical trials.

Bias

Optimum biased-coin designs for sequential treatment allocation with covariate information.

Randomized optimum designs of biased-coin type are compared with other strategies for the sequential allocation of two or more treatments in a clinical trial. The emphasis is on the variance of estimated treatment contrasts. This variance, which depends on the design strategy employed, may be interpreted as the number of patients on whom information is lost. Simulations provide clear plots of the evolution of this loss during the course of the clinical trial.

Bias